Generic Mitoxantrone Launches For Oncology Indications
This article was originally published in The Pink Sheet Daily
Serono still holds exclusivity for Novantrone’s multiple sclerosis indication.
You may also be interested in...
Serono and OSI added the warnings following cardiotoxicty reports from post-marketing surveillance and secondary acute myelogenous leukemia reports from peer-reviewed literature, spontaneous reports and a prospective observational study, a "Dear Doctor" letter states.
HAMBURG, Germany - Due to the increasingly global nature of biotechnology, the Biotechnology Industry Organization's board of directors will meet next month to discuss a proposal to expand its global reach and potentially create a department of international relations, BIO President Jim Greenwood said Nov. 13
Merger will create the leading generic injectable pharmaceutical company in the world.